WASHINGTON, June 7 (Reuters) - Patients who want an injectable form of Roche Holding AG's bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not ...

Nutley, NJ - An injectable form of ibandronate (Boniva, Roche/GlaxoSmithKline) that can be given once every three months has been approved by the US Food and Drug Administration (FDA) for treatment of ...

SAN FRANCISCO (MarketWatch) -- Roche and GlaxoSmithKline Plc said late Friday the Food and Drug Administration has approved Boniva Injection, the first intravenous medication for the treatment of ...

While drug shortages often are tied to manufacturing interruptions, Roche's ($RHHBY) injectable form of its osteoporosis drug Boniva will be in limited supply for ...

Mylan Launches Generic Xeloda Mylan announced the launch of Ibandronate Sodium Injection, the generic version of Roche's Boniva Injection. Boniva is a bisphosphonate that inhibits osteoclast activity ...

Many companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught off-guard by a lack of it, leading to a ...

A new treatment for osteoporosis that can be given just once every three months has been approved by the US Food and Drug Administration. A new treatment for osteoporosis that can be given just once ...

Roche announced the results from the first year of a phase III study (DIVA) investigating an intravenous injection of Bonviva/Boniva (ibandronate) with extended intervals between dosages, for the ...

WASHINGTON (Reuters) – Patients who want an injectable form of Roche Holding AG’s bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not accurately ...

Unlike Boniva tablets, which people take once a month, Boniva injections are given once every three months. The U.S. Food and Drug Administration announced the shortage of Boniva vials on its website ...